Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-02

FDA Approved: AZACITIDINE — Original Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved Accord Healthcare Inc.'s original application for azacitidine, providing a generic version of the cancer drug indicated for myelodysplastic syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZACITIDINE (AZACITIDINE)

Snippet

ORIG AP for AZACITIDINE (AZACITIDINE)